www.evvolve.io
Open in
urlscan Pro
34.249.200.254
Public Scan
Submitted URL: https://alliesfilinggroup.com/
Effective URL: https://www.evvolve.io/
Submission: On August 14 via automatic, source certstream-suspicious — Scanned from DE
Effective URL: https://www.evvolve.io/
Submission: On August 14 via automatic, source certstream-suspicious — Scanned from DE
Form analysis
2 forms found in the DOMName: wf-form-Newsletter-Form — GET
<form id="wf-form-Newsletter-Form" name="wf-form-Newsletter-Form" data-name="Newsletter Form" method="get" class="footer-form" data-wf-page-id="6601ea47f497e4b319acc379" data-wf-element-id="e1ab56b7-f9bf-0870-916d-44c1aabf9973"
aria-label="Newsletter Form"><input class="email-form w-input" maxlength="256" name="email-2" data-name="Email 2" placeholder="email" type="email" id="email-2" required="">
<div class="submit-wrapper">
<div class="footer-arrow-wrapper"><img loading="lazy" src="https://cdn.prod.website-files.com/6601ea47f497e4b319acc372/66a511717f78e27bf12cf631_Arrow%201%20(7).svg" alt="" class="footer-arrow"></div>
<div>Submit</div><input type="submit" data-wait="Please wait..." class="submit-button w-button" value="">
</div>
</form>
Name: email-form — GET
<form id="email-form" name="email-form" data-name="Email Form" method="get" class="footer-form" data-wf-page-id="6601ea47f497e4b319acc379" data-wf-element-id="b10040a0-161c-0761-44e3-6dc115e89dbc" aria-label="Email Form"><input
class="email-form w-input" maxlength="256" name="email-2" data-name="Email 2" placeholder="email" type="email" id="email-2" required="">
<div class="submit-wrapper">
<div class="footer-arrow-wrapper"><img loading="lazy" src="https://cdn.prod.website-files.com/6601ea47f497e4b319acc372/66a511717f78e27bf12cf631_Arrow%201%20(7).svg" alt="" class="footer-arrow"></div>
<div>Submit</div><input type="submit" data-wait="Please wait..." class="submit-button w-button" value="">
</div>
</form>
Text Content
VISIONTEAMCOMMITMENTSINSIGHTSCONTACT US LINKEDIN X VISIONTEAMCOMMITMENTSINSIGHTSCONTACT US CONNECTING YOU WITH THE RIGHT INVESTORS Vision WHY WE STARTED EVVOLVE At Evvolve, our mission is to empower venture capitalists, high net worth individuals, and family offices to discover promising investment opportunities with precision. COMMITMENTS Explore our history of deals, reflecting our commitment to transformative investment opportunities. View All View All THE FIRM Our mission at Evvolve is to connect disruptive entrepreneurs with strategic capital, ensuring growth and innovation. Meet Our Team EVVOLVE EVVOLVE EVVOLVE EVVOLVE INSIGHTS All News August 12, 2024 3min MERGERS, MIND CONTROL, AND MEDICAL BREAKTHROUGHS: THE WEEK'S TOP HIGHLIGHTS From mind-controlling implants to billion-dollar mergers, this week's biotech breakthroughs read like science fiction—except they're very real. Read July 23, 2024 3min REDEFINING POSSIBILITIES: BREAKTHROUGHS IN NEUROTECHNOLOGY AND IMMUNOLOGY This week's highlights showcase advancements in AI-driven research, innovative funding strategies, and cutting-edge biocomputing technologies that are revolutionizing the field. Read July 12, 2024 3min $200 MILLION SPEAKS: WHY INVESTORS ARE BETTING ON AI-POWERED DRUG DISCOVERY The biotechnology landscape continues to evolve at a breakneck pace, with groundbreaking developments reshaping the future of healthcare and drug discovery. Read July 6, 2024 4min SILICON VALLEY MEETS LIFE SCIENCES: AI, GENE EDITING, AND STRATEGIC PARTNERSHIPS Exciting developments are reshaping the landscape of biotechnology and healthcare innovation. Read August 12, 2024 3min MERGERS, MIND CONTROL, AND MEDICAL BREAKTHROUGHS: THE WEEK'S TOP HIGHLIGHTS From mind-controlling implants to billion-dollar mergers, this week's biotech breakthroughs read like science fiction—except they're very real. Read July 23, 2024 3min REDEFINING POSSIBILITIES: BREAKTHROUGHS IN NEUROTECHNOLOGY AND IMMUNOLOGY This week's highlights showcase advancements in AI-driven research, innovative funding strategies, and cutting-edge biocomputing technologies that are revolutionizing the field. Read July 12, 2024 3min $200 MILLION SPEAKS: WHY INVESTORS ARE BETTING ON AI-POWERED DRUG DISCOVERY The biotechnology landscape continues to evolve at a breakneck pace, with groundbreaking developments reshaping the future of healthcare and drug discovery. Read All News NEW YORK 99 Wall StreetNY 10005, United States DUBAI The Grand, Ras Al KhorDubai Creek Harbour, UAE HAMBURG Neuer Jungfernstieg 620354 Hamburg, Germany LONDON 71-75 Shelton StreetWC2H 9JQ, United Kingdom BOSTON MIAMI NEWSLETTER Find out first about hot deals and trends. Submit Thank you! Your submission has been received! Oops! Something went wrong while submitting the form. LINKEDIN Privacy Policy X Terms of Service VISIONTEAMCOMMITMENTSINSIGHTSCONTACT US Securities are offered through Finalis Securities LLC Member FINRA / SIPC. Evvolve & Partners LLC is not a registered broker-dealer, and Finalis Securities LLC and Evvolve & Partners LLC are separate, unaffiliated entities. Finalis Privacy Policy | Finalis Business Continuity Plan | FINRA BrokerCheck evvolve.io (the “Evvolve & Partners LLC Website”) is a website operated by Evvolve & Partners LLC, a privately held Wyoming limited liability company. Evvolve & Partners LLC provides, financial and strategic advisory, consulting services, mergers and acquisitions services, and capital raising services. © Evvolve & Partners 2024 VISIONTEAMCOMMITMENTSINSIGHTSCONTACT US LINKEDIN X NEWSLETTER Find out first about hot deals and trends. Submit Thank you! Your submission has been received! Oops! Something went wrong while submitting the form. Privacy PolicyTerms of Service NEW YORK 99 Wall Street NY 10005, United State DUBAI The Grand, Ras Al Khor Dubai Creek Harbour, UAE HAMBURG Neuer Jungfernstieg 6 20354 Hamburg, Germany LONDON 71-75 Shelton Street WC2H 9JQ, United Kingdom BOSTON MIAMI Securities are offered through Finalis Securities LLC Member FINRA / SIPC. Evvolve & Partners LLC is not a registered broker-dealer, and Finalis Securities LLC and Evvolve & Partners LLC are separate, unaffiliated entities. Finalis Privacy Policy | Finalis Business Continuity Plan | FINRA BrokerCheck evvolve.io (the “Evvolve & Partners LLC Website”) is a website operated by Evvolve & Partners LLC, a privately held Wyoming limited liability company. Evvolve & Partners LLC provides, financial and strategic advisory, consulting services, mergers and acquisitions services, and capital raising services. © evvolve & partners 2024